Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
- Age
- 45 – 74
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- AstraZeneca · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityObservational study that aims to evaluate the implementation of a lung cancer screening program in a smoker population included in a public heath service.
Loading trial locations…
AstraZeneca Clinical Study Information Center
1-877-240-9479
information.center@astrazeneca.com
CONTACT